CAS: 2209871-83-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | ETX0282 REF: 3D-FE178951CAS: 2209871-83-8 | Min. 95% | To inquire | Fri 27 Dec 24 |
 | ETX0282 REF: TM-T69797CAS: 2209871-83-8 | - - - | 3,139.00 €~5,767.00 € | Wed 12 Mar 25 |
ETX0282
CAS:2209871-83-8
ETX0282 is a covalent complex that contains an isopropyl group and a cyclic peptide. It …
Formula:
C13H18FN3O8
Purity:
Min. 95%
Molecular weight:
315.3 g/mol
Ref: 3D-FE178951
| Undefined size | To inquire |
Estimated delivery in United States, on Friday 27 Dec 2024
ETX0282
CAS:2209871-83-8
ETX0282, oral class A/C β-lactamase inhibitor, developed by Entasis with cefpodoxime for bacterial infections.
Formula:
C13H18FN3O5
Color and Shape:
Liquid
Molecular weight:
315.3
Ref: TM-T69797
| 25mg | 3,139.00 € | ||
| 50mg | 4,141.00 € | ||
| 100mg | 5,767.00 € |
Estimated delivery in United States, on Wednesday 12 Mar 2025
